Business ❯ Investing

Pharmaceuticals

Manufacturing Research and Development Biotechnology Roche Biologics Life Sciences Veterinary Medicine Biopharmaceuticals AstraZeneca Multinational Companies Concussion Drugs Mexico Ophthalmology Weight-Loss Drugs Contract Manufacturing Global Expansion Eli Lilly Mining Infrastructure Merck Vaccine Development Job Creation

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

The deal extends their B‑cell depletion work following Sanofi’s purchase of DR‑0201 earlier this year.

Merck Breaks Ground on $3 Billion Virginia Plant in $70 Billion U.S. Expansion

AstraZeneca Breaks Ground on $4.5 Billion Virginia Plant With Expanded Cancer and Obesity Drug Production

Eli Lilly Chooses Houston for $6.5 Billion Plant to Produce APIs for Orforglipron and Other Drugs

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

AbbVie to Build $195 Million API Facility in North Chicago

AstraZeneca Commits $50 Billion to U.S. Manufacturing and Research by 2030